IFC (Editorial Board)

of 1 /1
Aims and Scope: Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO). Authors who wish to submit reviews to the journal are requested to submit a short synopsis of their chosen subject to the Editor. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors. Editor-in-Chief: M.S. Aapro, Clinique de Genolier, Institut Multidisciplinaire d’Oncologie, Route du Muids 1, CH-1272 Genolier, Switzerland. Tel.: 41 22 366 9136; Fax: 41 22 366 9131; E-mail: [email protected] Subject Editors: Editorial Board: CRITICAL REVIEWS IN Ethics, Health Policy and Prevention L. Baider, Jerusalem, Israel V. Currie, New York, NY, USA A. Decensi, Genoa, Italy T. Gilewski, New York, NY, USA L. Grassi, Ferrara, Italy S. Joffe, Boston, MA, USA L. Schapira, Boston, MA, USA M. Zwitter, Zaloska, Solvenia Solid Tumors J. Bernier, Genolier, Switzerland J.Y. Blay, Lyon, France F. Cardoso, Lisbon, Portugal A. Costa, Lugano, Switzerland T. Cufer, Golnik, Slovenia P.-Y. Dietrich, Geneva, Switzerland R.R. Dobelbower, Toledo, OH, USA G. Gasparini, Rome, Italy P. Hohenberger, Mannheim, Germany R.D. Issels, Munich, Germany M. Janssen-Heijnen, Eindhoven, The Netherlands F. Levi, Lausanne, Switzerland G.H. Lyman, Durham, NC, USA R.G. Maki, New York, NY, USA L. Norton, New York, NY, USA N. Pavlidis, Ioannina, Greece D. Pfister, New York, NY, USA P. Price, Manchester, UK L. Repetto, Rome, Italy D. Santini, Rome, Italy G.V. Scagliotti, Turin, Italy H.-J. Schmoll, Halle, Germany A. Sobrero, Genoa, Italy J.-C. Soria, Villejuif, France R. Stupp, Lausanne, Switzerland R. Valdagni, Milan, Italy E. Van Cutsem, Leuven, Belgium D. Zaridze, Moscow, Russia Experimental Oncology E.G.E. de Vries, Groningen, The Netherlands D. Gewitz Richmond, VA, USA I. Irminger-Finger, Geneva, Switzerland F.L. Meyskens, CA, USA A. Puisieux, Lyon, France E. Szabo, Bethesda, MD, USA V. Tergaonkar, Singapore A.M. Thompson, Dundee, UK N. Zaffaroni, Milan, Italy Hematology F. Cavalli, Bellinzona, Switzerland T. Facon, Lille, France J.-L. Haroussean, Nantes, France S. Imashuku, Kyoto, Japan J. San Miguel, Salamanca, Spain Y. Yoshida, Kyoto, Japan Ethics and Health Policy: A. Surbone, Milan, Italy Solid Tumors: C. Sternberg, Rome, Italy Experimental Oncology: J. Robert, Bordeaux, France Hematology: L. Trümper, Gottingen, Germany Publication information: Critical Reviews in Oncology/Hematology (ISSN 1040-8428). For 2014, volumes 89-92 (12 issues) are scheduled for publication. Subscription prices are available upon request from the Publisher or from the Elsevier Customer Service Department nearest you or from this journal’s website (www.croh-online.com). Further information is available on this journal and other Elsevier products through Elsevier’s website (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch. For a full and complete Guide for Authors, please go to: www.croh-online.com Author inquiries For inquiries relating to the submission of articles (including electronic submission) please visit this journal’s homepage at www.croh-online.com. For detailed instructions on the preparation of electronic artwork, please visit http://www.elsevier.com/ artworkinstructions. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles at http://www.elsevier.com/trackarticle. You can also check our Author FAQs at http://www.elsevier.com/authorFAQ and/or contact Customer Support via http://support.elsevier.com. Printed by Henry Ling Ltd, Dorchester, UK.

Transcript of IFC (Editorial Board)

Page 1: IFC (Editorial Board)

Aims and Scope: Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fi elds of oncology and hematology written by experts from around the world. All review articles, invited or submitted spontaneously, are subject to peer review before fi nal acceptance. Critical Reviews in Oncology/Hematology is the Offi cial Journal of the European School of Oncology (ESO).

Authors who wish to submit reviews to the journal are requested to submit a short synopsis of their chosen subject to the Editor. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.

Editor-in-Chief:M.S. Aapro, Clinique de Genolier, Institut Multidisciplinaire d’Oncologie,

Route du Muids 1, CH-1272 Genolier, Switzerland. Tel.: �41 22 366 9136;Fax: �41 22 366 9131; E-mail: [email protected]

Subject Editors:

Editorial Board:

CRITICAL REVIEWS IN

Ethics, Health Policy and PreventionL. Baider, Jerusalem, IsraelV. Currie, New York, NY, USAA. Decensi, Genoa, ItalyT. Gilewski, New York, NY, USAL. Grassi, Ferrara, ItalyS. Joffe, Boston, MA, USAL. Schapira, Boston, MA, USAM. Zwitter, Zaloska, Solvenia

Solid TumorsJ. Bernier, Genolier, SwitzerlandJ.Y. Blay, Lyon, FranceF. Cardoso, Lisbon, PortugalA. Costa, Lugano, SwitzerlandT. Cufer, Golnik, SloveniaP.-Y. Dietrich, Geneva, SwitzerlandR.R. Dobelbower, Toledo, OH, USAG. Gasparini, Rome, ItalyP. Hohenberger, Mannheim, GermanyR.D. Issels, Munich, GermanyM. Janssen-Heijnen, Eindhoven, The NetherlandsF. Levi, Lausanne, SwitzerlandG.H. Lyman, Durham, NC, USAR.G. Maki, New York, NY, USAL. Norton, New York, NY, USAN. Pavlidis, Ioannina, GreeceD. Pfi ster, New York, NY, USAP. Price, Manchester, UK

L. Repetto, Rome, ItalyD. Santini, Rome, ItalyG.V. Scagliotti, Turin, ItalyH.-J. Schmoll, Halle, GermanyA. Sobrero, Genoa, ItalyJ.-C. Soria, Villejuif, FranceR. Stupp, Lausanne, SwitzerlandR. Valdagni, Milan, ItalyE. Van Cutsem, Leuven, BelgiumD. Zaridze, Moscow, Russia

Experimental OncologyE.G.E. de Vries, Groningen, The NetherlandsD. Gewitz Richmond, VA, USAI. Irminger-Finger, Geneva, SwitzerlandF.L. Meyskens, CA, USAA. Puisieux, Lyon, FranceE. Szabo, Bethesda, MD, USAV. Tergaonkar, SingaporeA.M. Thompson, Dundee, UKN. Zaffaroni, Milan, Italy

HematologyF. Cavalli, Bellinzona, SwitzerlandT. Facon, Lille, FranceJ.-L. Haroussean, Nantes, FranceS. Imashuku, Kyoto, JapanJ. San Miguel, Salamanca, SpainY. Yoshida, Kyoto, Japan

Ethics and Health Policy: A. Surbone, Milan, ItalySolid Tumors: C. Sternberg, Rome, Italy

Experimental Oncology: J. Robert, Bordeaux, FranceHematology: L. Trümper, Gottingen, Germany

Publication information: Critical Reviews in Oncology/Hematology (ISSN 1040-8428). For 2014, volumes 89-92 (12 issues) are scheduled for publication. Subscription prices are available upon request from the Publisher or from the Elsevier Customer Service Department nearest you or from this journal’s website (www.croh-online.com). Further information is available on this journal and other Elsevier products through Elsevier’s website (http://www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch. For a full and complete Guide for Authors, please go to: www.croh-online.com

Author inquiries For inquiries relating to the submission of articles (including electronic submission) please visit this journal’s homepage at www.croh-online.com. For detailed instructions on the preparation of electronic artwork, please visit http://www.elsevier.com/artworkinstructions. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher. You can track accepted articles at http://www.elsevier.com/trackarticle. You can also check our Author FAQs at http://www.elsevier.com/authorFAQ and/or contact Customer Support via http://support.elsevier.com.

Printed by Henry Ling Ltd, Dorchester, UK. Oncology

/Disseminating Research/Advancing Care/Improving Lives

A convenient one-stop resource that: • announces latest Articles-in-Press from Elsevier’s comprehensive

portfolio of Oncology journals• provides access to the new editions and archive of the

EJC News Focus updates• transmits free Podcasts from leading publications • keeps you informed on industry meetings and events• and much more…

Visit OncologyAdvance.com today. ONE CLICK ACCESS TO ESSENTIAL RESOURCES IN ONCOLOGY

Where cancer researchers andoncologists find the latest peer-reviewed research and reviews.